Frontiers in Oncology (Feb 2023)
Corrigendum: HER-2 positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Feb 2023)